Asco

Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference

Drug that stops cancer cells hiding and a breakthrough for pancreatic cancer among highlights from Asco conference – but there were also notes of cautionDoctors, scientists and researchers shared new research about ways to tackle cancer at the 2026 American Society of Clinical Oncology (Asco) annual meeting, the world’s largest cancer conference. The event in Chicago, attended by 40,000 health professionals, featured more than 200 sessions and 2,700 poster presentations on this year’s theme,...

Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference

Drug that stops cancer cells hiding and a breakthrough for pancreatic cancer among highlights from Asco conference – but there were also notes of cautionDoctors, scientists and researchers shared new research about ways to tackle cancer at the 2026 American Society of Clinical Oncology (Asco) annual meeting, the world’s largest cancer conference. The event in Chicago, attended by 40,000 health professionals, featured more than 200 sessions and 2,700 poster presentations on this year’s theme,...

Weight-loss drugs may cut breast cancer risk by up to 30%, study finds

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. Women who take GLP-1 medications, such as Ozempic or Mounjaro, are less likely to develop breast cancer, a new study has found. The findings, presented at the 2026 American Society of Clinical Oncology (ASCO) annual meeting, come from an analysis of more than 110,000 women aged between 45 and 80.

Could cancer vaccines be next? New treatment cuts melanoma risk by nearly 50%

A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period. The personalized mRNA cancer therapy, called intismeran autogene, combined with the cancer immunotherapy drug KEYTRUDA (pembrolizumab), is a collaboration between Merck and Moderna. The results from the phase 2b KEYNOTE-942 study were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on May 27.CLICK HERE FOR MORE HEALTH STORIESAfter about a five-year...

Cancer survivors saw major improvements in sleep and well-being with one weekly practice

Yoga is known to boost relaxation, strength and flexibility – and now a new study has found the practice could improve cancer survivors’ quality of life. A randomized trial led by the University of Rochester Medical Center found that a four-week yoga program significantly reduced insomnia, fatigue, anxiety and mood disturbances after cancer treatment. The findings were presented last week at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Cancer breakthrough as new 'game-changing' pill could DOUBLE survival time for most deadly diseases

Cancer breakthrough as new 'game-changing' pill could DOUBLE survival time for most deadly diseases Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that A “game-changing” daily pill helped almost double survival time for patients with the most deadly major cancer. Pancreatic cancer patients on the drug lived for twice as long as those on chemotherapy. The pill’s success is thought to be the...

GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer

GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit. A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over the...

Daily pill can double survival time for deadliest cancer, trial shows

A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest breakthroughs in decades. Currently, there are few treatments for pancreatic cancer, and most do little or nothing to help. For decades, scientists have worked relentlessly trying to find clever solutions for a form of cancer that is often found late.

Scientists were excited about a blood test for many cancers — but it failed a big trial. Here's what to know.

Cancer survivors may see surprising benefits from one specific exercise, study says

For many, surviving cancer comes with an automatic new lease on life but other survivors continue to experience physical and emotional challenges long after treatment ends. Yoga may significantly reduce the insomnia, fatigue and mood disturbances many survivors endure after remission, a recent clinical trial found. Mood disturbance and insomnia are "two of the most pervasive and troubling side effects experienced by cancer survivors for years after completing adjuvant treatments," the...